June 5, 2008 - Images from inside the body can be made with tiny cameras a patient swallows, but until now doctors have not been able to steer or control them.

A new device being developed uses magnets to steer and can even deliver images of the esophagus.

In collaboration with engineers from the manufacturer Given Imaging, the Israelite Hospital in Hamburg and the Royal Imperial College in London, researchers from the Fraunhofer Institute for Biomedical Engineering in Sankt Ingbert have developed the first control system for the camera pill.

June 5, 2008 - eHealth Global Technologies signed an agreement with the Rochester Regional Health Information Organization to provide the eHealthConnect Image Exchange service for a two-year initial term, allowing automated access to radiology imaging across the Rochester community and providing a link for the Monroe County Department of Public Health to access imaging studies for its work in TB tracking and other public health issues.

June 5, 2008 - GE Healthcare will provide electrocardiogram technologies (ECG) to the Chinese Olympic Committee (COC) for diagnosing cardiac fitness of competing Chinese athletes to help ensure they achieve optimum performance during the Beijing 2008 Olympic Games.

June 5, 2008 - Merge Healthcare Inc. is reorganizing its business operations and making changes in executive management, according to the company.

The company is reorganizing and renaming its operating divisions. Merge Healthcare North America (MHNA) has been renamed Merge Fusion. Cedara, its operating division located in Toronto, Ontario, will be renamed Merge OEM.

June 5, 2008 - NeuroLogica Corp. and its Korean distribution partner, Dong Kang Medical Systems, said the CereTom CT scanner has received clearance from the Korean Food and Drug Administration (KFDA) for medical capital device imaging.

The portable eight-slice CT scanner acquires 1.25-millimeter slices per rotation and is capable of performing NeCT, CT Perfusion, Xenon Perfusion and CT Angiography. According to the company, it is also optimal for use in the emergency room, intensive care unit and operating room because of its portability.

IsoRay Medical Inc.’s Proxcelan is a seed used in low dose radiation (LDR) permanent brachytherapy for prostate cancer. The reportedly fast-acting, high-energy medical isotope has demonstrated strong clinical results and is being heralded as the first leap forward in seed brachytherapy in 20 years.

June 4, 2008 - AdvanDx this week submitted for FDA 510(k) review its Yeast Traffic Light PNA FISH for detection of Candida yeast species from positive blood cultures.

June 4, 2008 - Scientists in the environmental healthcare unit at the University of Southampton in the U.K. found that infectious bacterium Clostridium difficile is killed when exposed to surfaces made of copper and its alloys, brass and bronze.

The results of the study have been published in the February 2008 issue of the Journal of Hospital Infection.

C. difficile is a leading cause of hospital infection in both the U.K. and the U.S. The spores can live in the environment for a long time and are resistant to a range of disinfectants, including alcohol gel.

June 4, 2008 - Vision-Sciences Inc. received approval from Underwriters Laboratories Inc. to affix the CE Mark to its new line of advanced digital, video-based flexible endoscopes, which come with an built-in light source, eliminating the need for a separate camera head, light cable and optical coupler.

Radiation oncologists know that one of the major challenges in their field today involves accurate dose delivery. Despite years of advancement in diagnosis and treatment in cancer, particularly the tough-to-reach cancers of the head and neck, lungs, prostate and more, significant room for improvement exists.


Subscribe Now